QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies

Rifampicin-resistant tuberculosis (RR-TB) involves treatment with many drugs that can prolong the QT interval; this risk may increase when multiple QT-prolonging drugs are used together. We assessed QT interval prolongation in children with RR-TB receiving one or more QT-prolonging drugs. Data were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ali Mohamed, Radtke, Kendra K., Hesseling, Anneke C., Winckler, Jana, Schaaf, H. Simon, Draper, Heather R., Solans, Belén P., van der Laan, Louvina, Hughes, Jennifer, Fourie, Barend, Nielsen, James, Garcia-Prats, Anthony J., Savic, Rada M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353402/
https://www.ncbi.nlm.nih.gov/pubmed/37358463
http://dx.doi.org/10.1128/aac.01448-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353402/
https://www.ncbi.nlm.nih.gov/pubmed/37358463
http://dx.doi.org/10.1128/aac.01448-22

Ejemplares similares